# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001013762-25-001596
Filing Date
2025-03-24
Accepted
2025-03-24 16:10:37
Documents
3
Period of Report
2025-04-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0231983-02.htm | DEF 14A | 290332
2 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1241797
3 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1190461
| Complete submission text file | 0001013762-25-001596.txt |  | 3642026

Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41224 | Film No.: 25764283
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)